(NASDAQ: BBNX) Beta Bionics's forecast annual revenue growth rate of 26.88% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Beta Bionics's revenue in 2025 is $88,570,000.On average, 12 Wall Street analysts forecast BBNX's revenue for 2025 to be $4,361,740,316, with the lowest BBNX revenue forecast at $4,163,409,354, and the highest BBNX revenue forecast at $4,525,732,067. On average, 12 Wall Street analysts forecast BBNX's revenue for 2026 to be $5,938,922,722, with the lowest BBNX revenue forecast at $5,220,440,744, and the highest BBNX revenue forecast at $6,655,643,715.
In 2027, BBNX is forecast to generate $8,063,111,168 in revenue, with the lowest revenue forecast at $6,411,307,013 and the highest revenue forecast at $9,271,147,042.